Nan Fung Life Sciences
Family officeHong Kong · Seed–Growth · 1 people tracked
Find your way into Nan Fung Life Sciences
Team · 1 people
from public directoriesWhat they invest in
from 3 of 5 portfolio companiesBiotech ×3Healthtech ×2Longevity ×1Medical Devices ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathBolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.
BiotechHealthtechMedical DevicesSan Francisco, US
Dr. Edgar G. Engleman(Founder)
Co-investorsPfizer Venture InvestmentsRA CapitalSamsara BioCapitalSofinnova VenturesVivo CapitalNovo Holdings+1 more
BiotechEvanston, US
Joseph R. Moskal(Chief Scientific Officer)Torsten M. Madsen(Chief Marketing Officer)Ashish Khanna(Secretary & Chief Business Officer)Norbert G. Riedel(Chief Executive Officer)
BoardLiam Ratcliffe(Director)Terry P. Gould(Director)
Co-investorsBain Capital Life SciencesFrazier Life SciencesLatterell Venture PartnersLongitude CapitalOUP (Osage University Partners)Agent Capital+2 more
San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.
Co-investorsARCH Venture PartnersDecheng CapitalAlexandriaDeerfield Management CompanyGV (Google Ventures)Northpond Ventures
Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates.
BiotechHealthtechLongevitySan Francisco, US
Thomas Rando(Co-founder)Joseph Rodgers(Co-founder)inTom Cheung(Co-founder)inTsang(Chief Business Officer)
Co-investorsAlexandriaKhosla VenturesR42 Group
San Diego DNA sequencing company behind the Sequencing by Binding short-read platform; acquired by Pacific Biosciences in 2021.
Co-investorsARCH Venture PartnersDecheng CapitalALTITUDE LIFE SCIENCE VENTURESDomain AssociatesHillhouse Capital
Exits · 1
IPOs and acquisitions across the tracked portfolioBolt BiotherapeuticsNASDAQ: BOLT
Portfolio news
latest coverage across their companiesOmniome · sif.gatesfoundation.org · Feb 3, 2026
Frequently asked questions
- What stage does Nan Fung Life Sciences invest at?
- Nan Fung Life Sciences invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Nan Fung Life Sciences focus on?
- Nan Fung Life Sciences focuses on Biotech.
- Where is Nan Fung Life Sciences located?
- Nan Fung Life Sciences is headquartered in Hong Kong, HK.
Similar investors
Rodrigo Sepúlveda Schulz is a senior technology executive and investor who leads the international expansion of Stratio.ai, an AI-powered decision intelligence platform for enterprises and governments, while serving as president of his family office, Sepulveda Capital. He has participated in over 100 financing transactions with a track record including three billion-dollar exits and extensive advisory work across technology ventures.
Vesalius Biocapital is a European life sciences venture capital investor focused on later-stage companies in drug development, medical devices and diagnostics, and eHealth/mHealth. Its active fund, Vesalius Biocapital III, closed in May 2019 with €120 million in commitments.
Roadmap Capital Inc. is an investment platform providing co-investment access to private companies in technology and healthcare/medtech sectors.
Eisai is a global pharmaceutical company built around its human health care (hhc) corporate philosophy, focused on developing treatments in neurology and oncology and addressing neglected tropical diseases.
Northern Gritstone is a UK investment firm backing science and technology startups in the North of England, focused on university spinouts and early-stage companies across the Northern Arc region.